180 related articles for article (PubMed ID: 32296463)
1. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
2. Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma.
Wu M; Wei B; Duan SL; Liu M; Ou-Yang DJ; Huang P; Chang S
Front Cell Dev Biol; 2022; 10():819484. PubMed ID: 35141223
[No Abstract] [Full Text] [Related]
3. A six-gene prognostic model predicts overall survival in bladder cancer patients.
Wang L; Shi J; Huang Y; Liu S; Zhang J; Ding H; Yang J; Chen Z
Cancer Cell Int; 2019; 19():229. PubMed ID: 31516386
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
5. Screening of key methylation-driven genes CDO1 in breast cancer based on WGCNA.
Tu S; Zhang H; Qu X
Cancer Biomark; 2022; 34(4):571-582. PubMed ID: 35342080
[TBL] [Abstract][Full Text] [Related]
6. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
7. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
8. Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Lu T; Chen D; Wang Y; Sun X; Li S; Miao S; Wo Y; Dong Y; Leng X; Du W; Jiao W
Cancer Cell Int; 2019; 19():52. PubMed ID: 30886542
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
Huang H; Fu J; Zhang L; Xu J; Li D; Onwuka JU; Zhang D; Zhao L; Sun S; Zhu L; Zheng T; Jia C; Cui B; Zhao Y
Front Oncol; 2021; 11():629860. PubMed ID: 34178621
[TBL] [Abstract][Full Text] [Related]
10. Construction of Novel Methylation-Driven Gene Model and Investigation of PARVB Function in Glioblastoma.
Yu W; Wu P; Wang F; Miao L; Han B; Jiang Z
Front Oncol; 2021; 11():705547. PubMed ID: 34568031
[TBL] [Abstract][Full Text] [Related]
11. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.
Wei J; Wang B; Gao X; Sun D
Front Cell Dev Biol; 2021; 9():648279. PubMed ID: 34336819
[TBL] [Abstract][Full Text] [Related]
13. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
14. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
[TBL] [Abstract][Full Text] [Related]
15. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
16. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
17. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
20. Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Chen Y; Wang K; Shang M; Zhao S; Zhang Z; Yang H; Chen Z; Du R; Wang Q; Chen B
J Comput Biol; 2021 Jan; 28(1):99-114. PubMed ID: 32790501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
